Clinical Trials Logo

Clinical Trial Summary

This is a Phase 2, multicenter, randomized, parallel, 3-arm, placebo-controlled study to assess efficacy and safety of CDR132L in patients with reduced Left Ventricular Ejection Fraction (LVEF) (≤ 45%) after myocardial infarction (MI). This study consists of a screening period (to occur at least 3 days after MI diagnosis), a 6-month double-blind period, and a 6-month extension period with the End of Study (EOS) Visit at Day 360/Month 12. Two dosages of CDR132L will be tested against placebo on their effects on patients, who just had a heart attack in addition to standard care. The aim of the study is to show that CDR132L is safe and effective to improve heart failure in such patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05350969
Study type Interventional
Source Cardior Pharmaceuticals GmbH
Contact
Status Active, not recruiting
Phase Phase 2
Start date June 27, 2022
Completion date March 11, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05759078 - Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion Phase 4
Completed NCT06408636 - Prognostic Role of LA Strain in Acute Myocardial Infarction
Recruiting NCT06038994 - Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction
Recruiting NCT04968808 - Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) N/A
Completed NCT03338504 - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting NCT03317691 - The ALERT-Pilot Study N/A
Active, not recruiting NCT05077683 - Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF Phase 3
Recruiting NCT03957005 - Cardiovascular Risk Assessment Model in Patients With MI
Enrolling by invitation NCT05955950 - Gratitude Intervention in Promoting Self-care in Patients With Myocardial Infarction N/A
Active, not recruiting NCT06141252 - Benefit of Hypothermia in OHCA Complicating AMI N/A
Not yet recruiting NCT04560023 - Effectiveness of Multimedia Exposure in Patients Transferred to Hospital Suffering From Acute Myocardial Infarction N/A
Terminated NCT03809689 - Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET N/A
Recruiting NCT06430892 - RAPID-POP a Randomized Controlled Trial N/A
Completed NCT05118009 - Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE) N/A
Active, not recruiting NCT04753749 - Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy N/A
Completed NCT04769219 - Secondary Prevention Education After Acute Myocardial Infarction N/A
Recruiting NCT05999110 - Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR) N/A
Completed NCT04167904 - Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Not yet recruiting NCT04989777 - IABP In AMI Patients With SCAI-B Study N/A
Recruiting NCT05043610 - MSCs for Prevention of MI-induced HF Phase 3